Virus Diseases

381 trials 107 recruiting

Filter these 381 trials by phase, country and sponsor.

Open in Search →

The Late Presenter Treatment Optimisation Study (LAPTOP) Ended

2023-505167-36-00 Patients who present late on during their acquisition o 5 2019-08-05
Dexamethasone in Herpes Simplex Virus Encephalitis Open label Randomized Controlled Trial with an Observer-blinded evaluation at 6 months Ended

2024-515985-16-00 Herpes Simplex Virus Encephalitis 5 2019-04-25
A study on the safety, efficacy and immune response following sequential treatment with an anti-sense oligonucleotide against chronic Hepati… Ended

2024-512352-38-00 Hepatitis B, Chronic 4 2019-03-28
"Safety, efficacy, immunogenicity study of GSK Biologicals’ HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) in adult patients… Ended

2023-510020-68-00 Hepatitis B, Chronic 7 2019-03-18
CONDYVAC. Efficacy study of the quadrivalent Human Papilloma Virus (HPV) vaccine to prevent recurrence of External Genital Warts (EGW) in pa… Ended

2024-516098-62-00 External Genital Warts (EGW) 5 2018-01-11
N/A Ended

2024-517526-26-00 Hepatitis B Infection 5 2012-12-06
MESENCHYMAL STROMAL CELL THERAPY FOR THE TREATMENT OF ACUTE RESPIRATORY DISTRESS SYNDROME - Validation of Mechanistic Pathways and Clinical … Ended

2024-518160-13-00 Acute Respiratory Distress Syndrome - ARDS 1
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA) Ended

2024-515487-31-00 HIV-infected 6
Phase 2 study of inhaled SNG001 in mechanically ventilated patients with respiratory virus infection Ended

2024-520375-27-00 Lower respiratory tract viral infections 4
Impact of post-Acute respiratory distress syndrome COVID sedation on late neuroinflammation (PET-DEXDOCOVID) Ended

2024-511898-30-00 Patients who survive a COVID ARDS in intensive care mus 5
Pilot study, open label, multicenter, evaluating dual antiretroviral therapy with long-acting cabotegravir/lenacapavir IMEA 069 - CALENDULA Ended

2024-516028-33-01 HIV infection 5
Durability of Immunity induced by the Ebolavirus Vaccine VSV-EBOV and Assessment of a Booster Dose for Pre-Exposure Prophylaxis in Individua… Ended

2024-517352-35-00 Ebola virus infection 10
A study to assess the immune response and safety of a vaccine against influenza in adults 18 years of age and older. Ended

2025-522278-35-00 Influenza, Human 4
A study to investigate the safety and tolerability of dostarlimab in adult participants with chronic HBV infection on nucleos(t)ide analogue… Ended

2023-509027-41-00 Hepatitis B, Chronic 3
A Randomized, Blinded, Placebo-Controlled Dose-Ranging Phase 1b Study of the Safety, Pharmacokinetics, and Antiviral Activity of ABI-4334 in… Ended

2024-511051-18-00 chronic hepatitis B virus infection (cHBV) 3
Study of Obeldesivir in Children and Adolescents With COVID-19 Ended

2023-503282-27-00 COVID-19 10
A randomized controlled trial to compare the immunogenicity and skin imprinting of intradermal and intramuscular rabies vaccination < RABISK… Ended

2023-507065-26-00 Rabies 5
Immune responses in health care personnel Ended

2024-515372-12-00 Influenza, Immunity against influenza 6
A Multiple-Dose Clinical Study to Evaluate Safety, Tolerability, and Pharmacokinetics of MK-8527 in Healthy Participants Expired

2022-502081-24-00 HIV-1 (Human Immunodeficiency Virus Type 1) 3
Evaluation and promotion of specific adaptative immunity against polyomavirus (BKV) to prevent viral infection after kidney transplantation … Expired

2023-504309-35-00 Prevention viral infection (BKV) poliamavirus after kid 6
A Phase 1/2a, Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of BJT-778… Expired

2022-502724-46-00 Chronic Hepatitis B Infection 9